|1.||Li, C L: 1 article (12/2006)|
|2.||Wu, Y: 1 article (12/2006)|
|3.||Miao, L D: 1 article (12/2006)|
|4.||Han, J: 1 article (12/2006)|
|5.||Liu, J W: 1 article (12/2006)|
|6.||Tang, W: 1 article (12/2006)|
|7.||Lan, M B: 1 article (12/2006)|
12/01/2006 - "The cytotoxicity of FC-TEMPO in the high metastatic lung carcinoma cells (95-D) showed that it markedly inhibited the viability of cancer cells in a dose-dependent manner, while it was less toxic to a normal human cell line. "
12/01/2006 - "Further studies found that FC-TEMPO suppressed the growth of tumor cells by induced apoptosis through activating caspase-3 but not caspase-8 which was proved by caspase inhibitors, and the cell cycle arrest at G1 phase. "
12/01/2006 - "A novel nitroxide derivative, 4-ferrocenecarboxyl-2,2,6,6-tetramethyl piperidine-1-oxyl (FC-TEMPO), was synthesized for evaluating the effects of spin label compounds on tumor cells and firstly its biological effects on tumor and normal cells were evaluated. "
|1.||Caspase 8 (Caspase-8)
|2.||Caspase 3 (Caspase-3)